J Korean Ophthalmol Soc > Volume 52(1); 2011 > Article
Journal of the Korean Ophthalmological Society 2011;52(1):23-28.
DOI: https://doi.org/10.3341/jkos.2011.52.1.23    Published online January 15, 2011.
Clinical Results of Riboflavin and Ultraviolet-A-induced Corneal Cross-linking for Progressive Keratoconus in Korean Patients.
Pyung Lee, Kyung Hyun Jin
Department of Ophthalmology, KyungHee University School of Medicine, Seoul, Korea. khjinmd@khmc.or.kr
한국인 진행성 원추각막 환자에서 각막 교차결합술의 임상 효과
Department of Ophthalmology, KyungHee University School of Medicine, Seoul, Korea
To report the clinical results of 10 progressive keratoconic eyes in Korean patients treated by corneal cross-linking and compare the progression of keratoconus in the fellow eyes. METHODS: This present retrospective case series was comprised of 10 progressive keratoconic eyes (10 patients) that had corneal cross-linking. Patients were examined before corneal cross-linking as well as 1, 3, 6, 9, and 12 months postoperatively. The main outcome measures were best corrected visual acuity, maximum keratometry, mean keratometry, corneal thickness, corneal astigmatism and endothelial cell count. RESULTS: The best corrected visual acuity (logMAR) improved from 0.60 +/- 0.39 to 0.52 +/- 0.38 at 12 months postoperatively. The maximum keratometry decreased from 62.39 +/- 8.82 D preoperatively to 60.21 +/- 9.21 D at 12 months postoperatively and the mean keratometry decreased from 51.59 +/- 5.86 D to 50.04 +/- 6.21 D at 12 months. In addition, the corneal thickness (at the thinnest area) decreased from 433.60 +/- 44.31 microm to 403.40 +/- 38.95 microm at 12 months. There was no statistically significant difference between the preoperative and 12 months postoperative endothelial cell count (p = 0.731). CONCLUSIONS: This present 1-year follow-up study of Korean keratoconus patients showed corneal cross-linking appeared to be effective in the stabilizing progression of keratoconus and improving best corrective visual acuity and keratometry.
Key Words: Corneal cross-linking;Keratoconus;Riboflavin;UV-A

Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next